Based on these findings, we detected the prevalence of serum anti-14-3-3 zeta autoantibody in liver cirrhosis (LC) patients, which is commonly considered a premalignant liver disease of HCC. The gene discussed is YWHAZ; the disease is laryngotracheoesophageal cleft.